Intressanta studier med Mylotarg (gemtuzumab ozogamizin)

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid    leukaemia (ALFA-0701): a randomised, open-label, phase 3 study 
Castaigne et al, Lancet, 2012 Apr 21;379(9825):1508-16 
https://pubmed.ncbi.nlm.nih.gov/22482940/ 

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial 
Lambert et al, Haematologica, 2019 Jan;104(1):113-119 
https://pubmed.ncbi.nlm.nih.gov/30076173/